Government cash injection for University spin-out company's stem cell researchJanuary 24, 2005A spin-out company from the University of Nottingham has been awarded around £250,000 of Government funding to develop innovative stem cell therapies that could one day provide new treatments for patients suffering from illnesses including Parkinson's disease and stroke. RegenTec, a company at the cutting-edge of regenerative medicine that specialises in the development of stem cell and tissue engineering technology, is a partner in two projects that have attracted a total of £3.7 million from the Department of Trade and Industry's Technology Programme. The first award, made to a five-partner consortium led by the company ReNeuron, will bring together science and industry experts to develop new stem cell products for commercial use in treating neurodegenerative diseases such as stroke, Huntington's disease and Parkinson's disease, as well as other illnesses including diabetes, blindness and cardiac disease.
RegenTec will be working on the development of delivery systems that provide a supportive environment for stem cells. Once administered, the stem cells either encourage the growth of tissue by triggering the body's own repair processes or themselves begin to grow and form new tissue. The second project, led by the company NovaThera, will aim to develop our understanding of the way in which cells grow and develop into specific cells for different functions. The research, which will initially focus on cells to repair bone, lung and liver tissue, will look at ways in which this growth can be effectively controlled or manipulated. RegenTec specialises in the development of a range of materials that can be injected to deliver cells directly to the area of the body where they are needed. The materials are designed to solidify upon injection to create templates for tissue repair known as scaffolds. The scaffolds aim to enhance the survival and function of the stem cells and provide a controlled environment that encourages the cells to grow. Research will also be carried out into ways of taking scarce stem cells and growing a larger supply for use in treating a range of patients and diseases. RegenTec, which is based at BioCity, Nottingham's groundbreaking new healthcare and bioscience innovation centre, was set up four years ago by The University of Nottingham's Professor Kevin Shakesheff. Welcoming the DTI grant funding, Professor Shakesheff said: "Stem cell technology could revolutionise the treatment of life-threatening or long-term diseases. These awards confirm RegenTec's position as a key partner in advancing regenerative medicine from The University of Nottingham's world-class research labs through to patient treatments. "I'm delighted that the partnership between the University and RegenTec is again generating biotech jobs at BioCity Nottingham." Nottingham, University of | |||||||||||||||||||||
|
Related Stem Cells Current Events and Stem Cells News Articles Forsyth scientists trigger cancer-like response from embryonic stem cells Scientists from The Forsyth Institute, working with collaborators at Tufts and Tuebingen Universities, have discovered a new control over embryonic stem cells' behavior. Yamanaka eliminates viral vector in stem cell reprogramming Shinya Yamanaka MD, PhD, of Kyoto University and the Gladstone Institute of Cardiovascular Disease (GICD) has taken another step forward in improving the possibilities for the practical application of induced pluripotent stem (iPS) cell technology. A link between mitochondria and tumor formation in stem cells Researchers report on a previously unknown relationship between stem cell potency and the metabolic rate of their mitochondria -a cell's energy makers. Stem cells with more active mitochondria also have a greater capacity to differentiate and are more likely to form tumors. Landmark study unlocks stem cell, DNA secrets to speed therapies In a groundbreaking study led by an eminent molecular biologist at Florida State University, researchers have discovered that as embryonic stem cells turn into different cell types, there are dramatic corresponding changes to the order in which DNA is replicated and reorganized. Fat injections can improve breast reconstruction -- jury's out on augmentation Injecting fat after breast reconstruction to correct implant wrinkling or dimpling may be safe and effective to improve breast shape. Mayo researchers explore issues related to multiple myeloma treatment Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients. Reversible 3-D cell culture gel invented Singapore's Institute of Bioengineering and Nanotechnology (IBN), which celebrates its fifth anniversary this year, has invented a unique user-friendly gel that can liquefy on demand, with the potential to revolutionize three-dimensional (3D) cell culture for medical research. The small cell neuroendocrine carcinoma of the ampulla of vater Ampullary small cell neuroendocrine carcinoma is extremely rare and has only been documented in few case reports and retrospective study. The patients with ampullary small cell neuroendocrine carcinoma usually presented after the age of 60 years, and a male predilection was observed. Researchers Find an Essential Gene for Forming Ears of Corn Cold Spring Harbor Laboratory (CSHL) professor David Jackson, Ph.D., and a team of plant geneticists have identified a gene essential in controlling development of the maize plant, commonly known in the United States as corn. Pittsburgh researchers identify source of multipotent stem cells with broad regenerative potential In a promising finding for the field of regenerative medicine, stem cell researchers at Children's Hospital of Pittsburgh of UPMC have identified a source of adult stem cells found on the walls of blood vessels with the unlimited potential to differentiate into human tissues such as bone, cartilage and muscle. More Stem Cells Current Events and Stem Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||